Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.

Ahmed Aboraya, Jennifer Schumacher, Ehab Abdalla, James LePage, Melanie McGhee, Deborah Butcher, Holly Griffin, Mohammed Shahda

Research output: Contribution to journalReview article

18 Scopus citations

Abstract

This case report describes an 18-year-old African American male who presented to a state psychiatric facility with symptoms of bizarre behavior, delusions and auditory hallucination. He was diagnosed with schizophrenia and treated with eight days of risperidone followed by five days of olanzapine. During this two-week period, this patient began to develop signs and symptoms of neuroleptic malignant syndrome (NMS). Two weeks after all neuroleptic medications were discontinued, all his vital signs and labs returned to baseline. This case report and others from literature suggest that risperidone and olanzapine may induce NMS in some patients.

Original languageEnglish (US)
Pages (from-to)63-65
Number of pages3
JournalThe West Virginia medical journal
Volume98
Issue number2
StatePublished - Jan 1 2002

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.'. Together they form a unique fingerprint.

Cite this